Focus: Tactile Medical develops pneumatic compression devices and wearable systems for lymphedema, venous insufficiency, and related conditions affecting cancer patients and those with chronic circulatory disease. The company operates as a medical device innovator with a focused specialty in non-pharmacologic, device-based therapeutics.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Stable — net +1 jobs in 30d
32 added, 31 removed. Backfill posture.
Tactile Medical is a device-focused company with strong commercial momentum but limited clinical pipeline depth—ideal for sales/marketing professionals seeking growth, risky for R&D or those seeking late-stage clinical validation.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Flagship pneumatic compression device with digital connectivity; addresses largest unmet need in cancer-related lymphedema management.
Help build intelligence for Tactile Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Tactile Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Specialized variant targeting post-surgical lymphedema in head/neck cancer survivors; expands addressable market into high-morbidity patient population.
Extends compression therapy platform to chronic venous disease and wound care; broadens commercial opportunity beyond oncology.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo